Prognostic significance of TIMP3 hypermethylation in post-treatment salivary rinse from head and neck squamous cell carcinoma patients

Carcinogenesis

Volumn 34, Issue 1, 2013, Pages 20-27

  Rettori, Marianna Marconato ^a   De carvalho, Ana Carolina ^a   Bomfim longo, Ana Luiza ^a   De oliveira, Cleyton Zanardo ^b   Kowalski, Luiz Paulo ^c   Carvalho, Andre Lopes ^b   Vettore, Andre Luiz ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b BARRETOS CANCER HOSPITAL   (Brazil)

^c A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; DNA METHYLATION; FEMALE; FOLLOW UP; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SALIVA; SALIVA ANALYSIS; SENSITIVITY AND SPECIFICITY; TUMOR GENE;

CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; RECURRENCE; SALIVA; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 84872144818     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs311     Document Type: Article

References (36)

1. Kim,L. et al. (2010) Head and neck cancer: changing epidemiology and public health implications. Oncology, 24, 915-919.
2. Hinerman,R.W. et al. (2004) Postoperative irradiation for squamous cell carcinoma of the oral cavity: 35-year experience. Head Neck, 26, 984-994.
3. Spafford,M.F. et al. (2001) Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis. Clin. Cancer Res., 7, 607-612.
4. Palmisano,W.A. et al. (2000) Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res., 60, 5954-5958.
5. Hoque,M.O. et al. (2004) Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer. Cancer Res., 64, 5511-5517.
6. Lee,A. et al. (2004) Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast. Arch. Pathol. Lab. Med., 128, 1251-1256.
7. Hu,S. et al. (2006) Detection of serum deoxyribonucleic acid methylation markers: a novel diagnostic tool for thyroid cancer. J. Clin. Endocrinol. Metab., 91, 98-104.
8. Wadsworth,J.T. et al. (2004) Identification of patients with head and neck cancer using serum protein profiles. Arch. Otolaryngol. Head Neck Surg., 130, 98-104.
9. Wong,I.H. et al. (2003) Quantitative analysis of tumor-derived methylated p16INK4a sequences in plasma, serum, and blood cells of hepatocellular carcinoma patients. Clin. Cancer Res., 9, 1047-1052.
10. Usadel,H. et al. (2002) Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res., 62, 371-378.
11. Sanchez-Cespedes,M. et al. (2000) Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res., 60, 892-895.
12. Sun,W. et al. (2012) Detection of TIMP3 promoter hypermethylation in salivary rinse as an independent predictor of local recurrence-free survival in head and neck cancer. Clin. Cancer Res., 18, 1082-1091.
13. Demokan,S. et al. (2010) KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses. Int. J. Cancer, 127, 2351-2359.
14. Carvalho,A.L. et al. (2008) Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. Clin. Cancer Res., 14, 97-107.
15. Viet,C.T. et al. (2008) Methylation array analysis of preoperative and postoperative saliva DNA in oral cancer patients. Cancer Epidemiol. Biomarkers Prev., 17, 3603-3611.
16. Righini,C.A. et al. (2007) Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence. Clin. Cancer Res., 13, 1179-1185.
17. Rosas,S.L. et al. (2001) Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res., 61, 939-942.
18. Ha,P.K. et al. (2006) Promoter methylation and inactivation of tumoursuppressor genes in oral squamous-cell carcinoma. Lancet Oncol., 7, 77-82.
19. Cottrell,S.E. et al. (2003) Sensitive detection of DNA methylation. Ann. N. Y. Acad. Sci., 983, 120-130.
20. Bernard,P.S. et al. (2002) Real-time PCR technology for cancer diagnostics. Clin. Chem., 48, 1178-1185.
21. Eads,C.A. et al. (2000) MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res., 28, E32.
22. Vidal,D.O. et al. (2007) Aberrant methylation in pediatric myelodysplastic syndrome. Leuk. Res., 31, 175-181.
23. de Carvalho,F. et al. (2009) TGFbetaR2 aberrant methylation is a potential prognostic marker and therapeutic target in multiple myeloma. Int. J. Cancer, 125, 1985-1991.
24. Brabender,J. et al. (2001) Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival. Oncogene, 20, 3528-3532.
25. Leemans,C.R. et al. (2011) The molecular biology of head and neck cancer. Nat. Rev. Cancer, 11, 9-22.
26. Madu,C.O. et al. (2010) Novel diagnostic biomarkers for prostate cancer. J. Cancer, 1, 150-177.
27. Kaur,J. et al. (2010) Promoter hypermethylation in Indian primary oral squamous cell carcinoma. Int. J. Cancer, 127, 2367-2373.
28. Shiga,K. et al. (2012) Differences between oral cancer and cancers of the pharynx and larynx on a molecular level. Oncol. Lett., 3, 238-243.
29. Carvalho,A.L. et al. (2011) Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance. Clin. Cancer Res., 17, 4782-4789.
30. Neville,B.W. et al. (2002) Oral cancer and precancerous lesions. CA. Cancer J. Clin., 52, 195-215.
31. Molinolo,A.A. et al. (2009) Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncol., 45, 324-334.
32. Allen,C.T. et al. (2007) Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck. Head Neck, 29, 959-971.
33. Whiteside, T.L. (2008) The tumor microenvironment and its role in promoting tumor growth. Oncogene, 27, 5904-5912.
34. Gonda,T.A. et al. (2009) Chronic inflammation, the tumor microenvironment and carcinogenesis. Cell Cycle, 8, 2005-2013.
35. Slaughter,D.P. et al. (1953) Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer, 6, 963-968.
36. Sun,W. et al. (2012) Comparison of promoter hypermethylation pattern in salivary rinses collected with and without an exfoliating brush from patients with HNSCC. PLoS ONE, 7, e33642.